JZL184,1101854-58-3

公告提醒：爱必信所有产品和服务仅用于科学研究，不用于临床应用及其他用途提供产品和服务（也不为任何个人提供产品和服务）!

抑制剂描述：

产品名称：JZL184

产品别名：见爱必信官网

英文别名：JZL184

靶点：Lipase

CAS：1101854-58-3

纯度：>97%

外观：见爱必信官网

保存方法：Store at -20℃ for one year（Powder）；Store at 2-4℃ for two weeks；Store at -20℃ for six months after dissolution.

描述：

JZL184是第一个选择性的Monoacylglycerol lipase (MAGL)（单酰基甘油脂肪酶）抑制剂，IC50为8 nM。JZL184是用于研究内源性2-AG的信号的作用的有用工具。 JZL184时间依赖性地抑制MAGL，选择性为FAAH的300倍以上。JZL184不与CB1或CB2受体相互作用，并且不抑制2-AG的生物合成酶的二酰基甘油脂肪酶-α和二酰基甘油脂肪酶-β，或花生四烯酸动员酶胞浆型磷脂酶A2组IVA。

溶解性：DMSO ：93 mg/mL (178.7 mM)

体外研究：

JZL184 is a useful tool for studying the effects of endogenous 2-AG signaling. JZL184 displays time-dependent inhibition of MAGL and exhibits >300-fold selectivity for MAGL over FAAH in vitro. JZL184 does not interact with CB1 or CB2 receptors and does not inhibit the 2-AG biosynthetic enzymes diacylglycerol lipase-αand diacylglycerol lipase-β, or the arachidonic acid–mobilizing enzyme cytosolic phospholipase A2 group IVA.

体内研究：JZL184 produced a rapid and sustained blockade of brain 2-AG hydrolase activity in mice, resulting in eight-fold elevations in endogenous 2-AG levels that are maintained for at least 8 h. JZL184-treated mice showed a wide array of CB1-dependent behavioral effects, including analgesia, hypomotility and hypothermia, that suggest a broad role for 2-AG–mediated endocannabinoid signaling throughout the mammalian nervous system.

产品信息订购：

产品更多信息请进入爱必信(absin)商城查看》》》

absin，您身边的科研百宝箱
专业提供试剂、耗材、仪器，在线订购，7*24h全国发货，方便快捷！